reference/8834845

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8834845

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	6147
issn	1557-3265 1078-0432
issueIdentifier	20
pageRange	6141-6147
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	6141
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_206db5738edf7da5a12cb7304dadc674 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_99c12ae015ad40aa71e5c712d98bcbab
bibliographicCitation	Lee DW, Han SW, Bae JM, Jang H, Han H, Kim H, Bang D, Jeong SY, Park KJ, Kang GH, Kim TY. Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin. Clin Cancer Res. 2019 Oct 15;25(20):6141–7. doi: 10.1158/1078-0432.ccr-19-1105. PMID: 31285374.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3275-431X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b92d9543153a44be22c507323f984e80 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3f2cd76bcd147aa52c0447393dc8493 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0462-3072 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68b365fc117761a79c9d4cceff36fe71 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91e27552fbc9dc98ae5becd9a12f8d22 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8030dce79cf818a10804044c3db5519 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b33409508b07c60d968f07b55af12ef6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2380-6675 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7c86e957fd2e34f2896a9976e811ade
date	2019-10-15^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/31285374 https://doi.org/10.1158/1078-0432.ccr-19-1105
isPartOf	https://portal.issn.org/resource/ISSN/1078-0432 https://portal.issn.org/resource/ISSN/1557-3265 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin
discusses	http://id.nlm.nih.gov/mesh/M0015422 http://id.nlm.nih.gov/mesh/M0015632 http://id.nlm.nih.gov/mesh/M0004519 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0287377 http://id.nlm.nih.gov/mesh/M0008631
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015179Q000235 http://id.nlm.nih.gov/mesh/D009364Q000453 http://id.nlm.nih.gov/mesh/D014408Q000235 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D010071Q000627 http://id.nlm.nih.gov/mesh/D000069287Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004252 http://id.nlm.nih.gov/mesh/D015179Q000628 http://id.nlm.nih.gov/mesh/D017024Q000379 http://id.nlm.nih.gov/mesh/D015179Q000401 http://id.nlm.nih.gov/mesh/D015179Q000473 http://id.nlm.nih.gov/mesh/D012007Q000473 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D012007Q000601 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D009944Q000627 http://id.nlm.nih.gov/mesh/D009364Q000235 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D053842 http://id.nlm.nih.gov/mesh/D005472Q000627 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D003106Q000601 http://id.nlm.nih.gov/mesh/D003106Q000473 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D002955Q000627 http://id.nlm.nih.gov/mesh/D059014 http://id.nlm.nih.gov/mesh/D009154
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141643 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9887053 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11010

Showing number of triples: 1 to 73 of 73.